Hypertension in Type 2 Diabetes
Understanding diabetes
Research Team: Dr. Wayne Putnam, Dr. Fred Burge, Dr. Nandini Natarajan, Beverley Lawson, Celeste Latter, Kristine VanAarsen
A team of Maritime community family doctors and university researchers from the Department of Family Medicine at Dalhousie University brought together to improve primary care of patients with type 2 diabetes and hypertension.
- Over 1100 patients from family practices across the Maritimes participated in this study
- Data was abstracted from patients’ medical records
- A patient survey was also conducted to explore the lifestyle, habits and attitudes of patients with hypertension and type 2 Diabetes.
The project is complete. We thank all of the patients who consented to participate, their family physicians, their health care providers and the funding agencies for supporting this project.
Funding | |
---|---|
2004-2005 | Nova Scotia Health Research Foundation ($19,996) (Community Research Alliance Grant) Hypertension in patients with type 2 diabetes mellitus |
2005-2006 |
Prince Edward Island Health Research Institute ($4,884) Hypertension in patients with type 2 diabetes mellitus |
2007 | Capital District Health Authority ($13,518) Equipment grant: 17 BpTRU machines for use in RPP-funded |
2006-2009 | Canadian Institutes of Health Research ($132,443) Hypertension in type 2 diabetes in primary care: How much do drugs matter in reaching target blood pressures? |
Publications:
Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Canadian Family Physician 2013 Feb;59(2):e93-e100. View the publication.
Lawson B, Van Aarsen K, Latter C, Putnam W, Natarajan N, Burge F. Self-reported health beliefs, lifestyles and health behaviours in community-based patients with diabetes and hypertension. Canadian Journal of Diabetes. 2011;35(5):490-496.
Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine R, Hall J, Lacey K, MacDonald I, Burge I, Natarajan N, Sketris I, Mann B, Dunbar P, Van Aarsen K, Godwin M. Hypertension and type 2 diabetes: What family physicians can do to improve control of blood pressure-an observational study. BMC Family Practice 2011;12:86. View the publication.
Putnam W, Lawson B, Latter C, Burge F, Natarajan N, Sketris I, Mann E, Buhariwalla F, Goodfellow M, Hall J, Smith P. The impact of BpTRU on proportion at BP target in a cohort of patients with type 2 diabetes and hypertension (abstract). Canadian Journal of Cardiology 2009;25(SupplSB), Abstract #249.
Putnam W, Buhariwalla F, Lacey K, Goodfellow M, Goodine RA, Hall J, MacDonald I, Murray M, Smith P, Burge F, Natarajan N, Lawson B. Drug management of hypertension in type 2 diabetes in family practice. Canadian Family Physician 2009;55(July):728-34. View the publication.
Presentations:
Natarajan N, Latter C, Buhariwalla F, Goodfellow M, Goodine RA, Hall J, Lacey K, MacDonald I, Murray M, Smith P, Lawson B, Burge F, Putnam W, Godwin M, Dunbar P, Sketris I, Mann E. Adherence to antihypertensive medication in primary care patients with type 2 diabetes. North American Primary Care Research Group (NAPCRG) annual meeting, 2009. Montreal, QC. Family Medicine Forum 2009. Calgary AB.
Hall J, Buhariwalla F, Burge F, Godwin F, Goodfellow M, Goodine RA, Lacey K, Latter C< Lawson B, MacDonald I, Mann E, Natarajan N, Putnam W, Sketris I, Smith P. A comparison of BpTru and sphygmomanometer blood pressure in patients with type 2 diabetes. Family Medicine Forum 2009. Calgary AB.
Natarajan N, Buhariwalla F, Burge F, Dunbar P, Godwin M, Goodfellow M, Goodine RA, Hall J, Lacey K, Latter C, Lawson B, MacDonald I, Mann E, Murray M, Putnam W, Setris I, Smith P. Self-reported comorbidities and disease burden in a community cohort of patients with type 2 diabetes and hypertension. Family Medicine Forum 2009. Calgary AB.
Latter C, Lawson B, Buhariwalla F, Goodfellow M, Goodine RA, Hall J, Lacey K, MacDonald I, Murray M, Smith P, Natarajan N, Burge F, Putnam W. “At target” or “Not at target”? Standards shift perceptions of quality of hypertension care in patients with type 2 diabetes. North American Primary Care Research Group (NAPCRG) annual meeting, 2007. Vancouver, BC.
Smith P, Hall J, Putnam W, Buhariwalla F, Lacey K, Goodfellow M, Goodine RA, MacDonald I, Murray M, Burge F, Natarajan N, Lawson B. Hypertension in type 2 diabetic patients. 42nd Conjoint Scientific Assembly, Aug 2007. Charlottetown, PE.
Putnam W, Lawson B, Buhariwalla F, Goodfellow M, Goodine RA, Hall J, Lacey K, MacDonald I, Murray M, Smith P, Burge F, Natarajan N. Drug therapy of hypertension in type 2 diabetic patients. Family Medicine Forum, 2006. Quebec, QC.
Natarajan N, Hall J, Smith P, Buhariwalla F, Burge F, Goodfellow M, Goodine RA, Lacey K, MacDonald I, Murray M, Putnam W, Bower K. Diabetic nephropathy in a cohort of primary care patients with type 2 diabetes: Baseline data from the Maritime Family Practice Research Network. Family Medicine Forum, 2005, Vancouver, BC.
Putnam W, Bower K. Buhariwalla F, Burge F, Goodfellow M, Goodine RA, Hall J, Kiceniuk D, Lacey K, MacDonald I, Murray M, Natarajan N, Smith P. Creating a family practice research network to study hypertension in patients with type 2 diabetes. North American Primary Care Research Group (NAPCRG) Annual Conference, 2005. Quebec, QC.